Suncoast Clinical Research is evaluating an investigational oral medication to learn if it may help slow or improve symptoms of early Alzheimer’s. You could help advance future care—while receiving no-cost study-related care and close medical monitoring.
Early Alzheimer’s Oral Medication Study
Age Range:
55 to 85
Gender:
Male and Female
Location:
New Port Richey
About the Study
This clinical research study is evaluating an investigational oral medication to see if it may help slow or improve symptoms in people with early-stage Alzheimer’s disease.
Participants will take the study medication or a placebo daily at home for up to 18 months, with approximately 7 clinic visits. The goal is to better understand how this potential treatment affects memory and daily functioning.
Qualifications
You may qualify if you:
- Are 55 to 85 years old
- Have been diagnosed with early Alzheimer’s disease
- Have mild memory changes or early symptoms
- Have a caregiver or loved that can be involved in study visits
* Other qualifications apply during screening